Health

COVID-19 tablets available at some pharmacies in Texas

TEAXS — The Food and Drug Administration recently approved two COVID-19 antivirals, which are now available at some pharmacies in Wal-Mart and Sam’s Club, Texas.


What you need to know

  • Wal-Mart announced that the COVID-19 antivirals manufactured by Pfizer and Merck are now available at some pharmacies in Texas.
  • The drug will be in limited supply for the time being and will require a prescription
  • Pfizer was 89% effective in reducing the risk of hospitalization or death if the drug Paxlovid was given within 3 days of onset and within 5 days in early December. Said it was 88% effective.
  • Molnupiravir, a Merck pill, has been shown in clinical trials to reduce the risk of hospitalization and death in high-risk patients by 30%.

According to Wal-Mart, Pfizer’s Pax Rovid and Melk’s Molnupiravir require a prescription and will be available as long as supply permits.

Click here to see if the drug is available at your local Wal-Mart or Sam’s Club pharmacy.

A check on Friday morning showed that antivirals were available at eight stores in the Austin area, 40 pharmacies in the Dallas area, and a few pharmacies near San Antonio.

The drug is intended for people who test positive for COVID-19, so it can only be obtained from a curbside pickup or drive-through pharmacy window.

Kevin Host, Senior Vice President of Pharmacy, said: “This medicine gives customers the option of recovering at home and helps reduce the burden on hospitals and communities.”

Pfizer announced in early December that the COVID-19 pill was very effective in preventing serious illness and death. He also said that it is effective against the newly discovered Omicron mutant.

According to Pfizer, Paxrovid reduces the risk of hospitalization or death by 89% when administered within 3 days of onset and 88% when administered within 5 days.

“This news is meaningful to many people’s lives as it further supports the effectiveness of PAXLOVID in reducing hospitalization and mortality when oral antiviral candidates are approved or approved, and shows a significant reduction in viral load. It’s even more supportive of the potential impact, “Pfizer CEO Albert Bourla said in a statement. “This highlights the potential of treatment candidates to save lives for patients around the world.”

Molnupiravir, a collaborative effort between Merck and Ridgeback Biotherapeutics, has reduced the risk of hospitalization and death in high-risk patients by 30% in clinical trials.

Merck tablets have been approved for patients over the age of 18 who are at high risk of serious illness due to COVID-19. “The alternative COVID-19 treatment options approved by the FDA are inaccessible or clinically inadequate.”

COVID-19 tablets available at some pharmacies in Texas

Source link COVID-19 tablets available at some pharmacies in Texas

Back to top button